By an Order of the President dated 15 December 2021, the time for the CMA to file a consolidated Defence is extended until 14 January 2022.
A case management conference took place remotely on 21 January 2022 at which the Tribunal made case management directions and ordered that all appeals of the CMA's Liothyronine Decision will be case managed and heard together (the "Liothyronine Proceedings"). The Tribunal also made directions for the Liothyronine Proceedings to be progressed and case managed through the use of Ambulatory Drafts.
The hearing of the Liothyronine Proceedings took place between 26 September 2022 and 14 October 2022. Judgment is reserved.